文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

在埃塞俄比亚北部的 Lay Gayint,不同类型皮肤利什曼病患者的人口统计学特征和临床特征。

Demographic characteristics and clinical features of patients presenting with different forms of cutaneous leishmaniasis, in Lay Gayint, Northern Ethiopia.

机构信息

Department of Medical Laboratory Science, College of Medicine and Health Science, Bahir Dar University, Bahir Dar, Ethiopia.

Institute of Biotechnology, Bahir Dar University, Bahir Dar, Ethiopia.

出版信息

PLoS Negl Trop Dis. 2024 Aug 15;18(8):e0012409. doi: 10.1371/journal.pntd.0012409. eCollection 2024 Aug.


DOI:10.1371/journal.pntd.0012409
PMID:39146362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11349221/
Abstract

Cutaneous leishmaniasis (CL) is a neglected tropical disease caused by Leishmania parasites, that can cause long-term chronic disabilities. The clinical presentation of CL varies in both type and severity. CL presents as three main clinical forms: localised lesions (localised cutaneous leishmaniasis, LCL); mucocutaneous leishmaniasis (MCL) that affects the mucosa of the nose or the mouth; or as disseminated not ulcerating nodules (diffuse cutaneous leishmaniasis, DCL). Here we recruited a cohort of CL patients in a newly established leishmaniasis treatment centre (LTC) in Lay Gayint, Northwest Ethiopia, and collected detailed demographic and clinical data. The results of our study show that more males than females present to the LTC to seek diagnosis and treatment. 70.2% of CL patients presented with LCL and 20.8% with MCL. A small number of patients presented with DCL, recidivans CL (a rare form of CL where new lesions appear on the edges of CL scars) or with a combination of different clinical presentations. The duration of illness varied from 1 month to 180 months. Over a third of CL patients had additional suspected CL cases in their household. Despite the majority of CL patients having heard about CL, only a minority knew about its transmission or that it could be treated. Most CL patients lived in areas where environmental factors known to be associated with the transmission of CL were present. This work highlights that CL is an important public health problem in Lay Gayint and emphasises the urgent need for more CL awareness campaigns, better health education and better disease management practices.

摘要

皮肤利什曼病(CL)是一种由利什曼原虫引起的被忽视的热带病,可导致长期慢性残疾。CL 的临床表现在类型和严重程度上有所不同。CL 主要有三种临床表现形式:局限性病变(局限性皮肤利什曼病,LCL);黏膜皮肤利什曼病(MCL),影响鼻子或口腔的黏膜;或弥漫性非溃疡性结节(弥漫性皮肤利什曼病,DCL)。在这里,我们在埃塞俄比亚西北部的 Lay Gayint 新成立的利什曼病治疗中心(LTC)招募了一组 CL 患者,并收集了详细的人口统计学和临床数据。我们的研究结果表明,更多的男性而不是女性到 LTC 寻求诊断和治疗。70.2%的 CL 患者表现为 LCL,20.8%的患者表现为 MCL。少数患者表现为 DCL、复发性 CL(一种罕见的 CL 形式,新病变出现在 CL 疤痕的边缘)或具有不同临床表现的组合。疾病持续时间从 1 个月到 180 个月不等。超过三分之一的 CL 患者在其家庭中还有其他疑似 CL 病例。尽管大多数 CL 患者听说过 CL,但只有少数人知道它的传播途径或可以治疗。大多数 CL 患者生活在已知与 CL 传播有关的环境因素存在的地区。这项工作强调了 CL 是 Lay Gayint 的一个重要公共卫生问题,并强调了急需开展更多的 CL 宣传活动、加强健康教育和改善疾病管理实践。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d0/11349221/f8f8210f39e8/pntd.0012409.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d0/11349221/0674813a498a/pntd.0012409.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d0/11349221/8de5505c3fd7/pntd.0012409.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d0/11349221/60815c7b17db/pntd.0012409.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d0/11349221/f8f8210f39e8/pntd.0012409.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d0/11349221/0674813a498a/pntd.0012409.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d0/11349221/8de5505c3fd7/pntd.0012409.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d0/11349221/60815c7b17db/pntd.0012409.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65d0/11349221/f8f8210f39e8/pntd.0012409.g004.jpg

相似文献

[1]
Demographic characteristics and clinical features of patients presenting with different forms of cutaneous leishmaniasis, in Lay Gayint, Northern Ethiopia.

PLoS Negl Trop Dis. 2024-8

[2]
Cutaneous leishmaniasis in a newly established treatment centre in the Lay Gayint district, Northwest Ethiopia.

Skin Health Dis. 2023-3-17

[3]
Clinical features and treatment response of cutaneous leishmaniasis in North-West Ethiopia.

Trop Med Int Health. 2017-10

[4]
Cutaneous leishmaniasis a neglected tropical disease: community knowledge, attitude and practices in an endemic area, Northwest Ethiopia.

BMC Infect Dis. 2019-10-16

[5]
Clinical pattern and treatment outcome of Cutaneous Leishmaniasis in two hospitals in Bahir Dar, Ethiopia (2017-2021).

J Infect Dev Ctries. 2022-8-31

[6]
Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital.

Parasit Vectors. 2020-1-13

[7]
Investigation of parasite genetic variation and systemic immune responses in patients presenting with different clinical presentations of cutaneous leishmaniasis caused by Leishmania aethiopica.

Infect Dis Poverty. 2024-10-16

[8]
Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL).

Front Cell Infect Microbiol. 2021

[9]
Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns.

Trans R Soc Trop Med Hyg. 2009-7

[10]
Detection of Cutaneous Leishmaniasis Foci in South Ethiopia.

Am J Trop Med Hyg. 2021-5-10

引用本文的文献

[1]
Spatial Epidemiology of Clinical Forms of Cutaneous Leishmaniasis and Treatment Practice: Evidence from Leishmaniasis Research and Treatment Center, Northwest Ethiopia.

Iran J Parasitol. 2025

[2]
Cytokine Production in Response to Soluble Leishmania Aethiopica Antigen by Whole Blood Cells from Patients with Different Clinical Presentations of Cutaneous Leishmaniasis.

Am J Trop Med Hyg. 2025-2-11

[3]
Natural Product Identification and Molecular Docking Studies of Leishmania Major Pteridine Reductase Inhibitors.

Pharmaceuticals (Basel). 2024-12-24

[4]
Distinct neutrophil effector functions in response to different isolates of Leishmania aethiopica.

Parasit Vectors. 2024-11-11

[5]
Investigation of parasite genetic variation and systemic immune responses in patients presenting with different clinical presentations of cutaneous leishmaniasis caused by Leishmania aethiopica.

Infect Dis Poverty. 2024-10-16

本文引用的文献

[1]
Disseminated Leishmaniasis, a Severe Form of Leishmania braziliensis Infection.

Emerg Infect Dis. 2024-3

[2]
Cutaneous leishmaniasis in a newly established treatment centre in the Lay Gayint district, Northwest Ethiopia.

Skin Health Dis. 2023-3-17

[3]
Knowledge, attitude, and practice of the rural community about cutaneous leishmaniasis in Wolaita zone, southern Ethiopia.

PLoS One. 2023

[4]
Epidemiological and clinical characteristics of cutaneous leishmaniasis among patients attending at Tefera Hailu Memorial Hospital, Sekota, Northeast Ethiopia: A five-year trend analysis (2016-2020).

SAGE Open Med. 2022-10-11

[5]
Knowledge, attitude, and practices towards cutaneous leishmaniasis in referral cases with cutaneous lesions: A cross-sectional survey in remote districts of southern Khyber Pakhtunkhwa, Pakistan.

PLoS One. 2022

[6]
Knowledge, attitude and prevention measures of students towards cutaneous leishmaniasis in Delanta district, Northeast Ethiopia.

Parasite Epidemiol Control. 2022-1-25

[7]
A Ten-Year Trend of Cutaneous Leishmaniasis at University of Gondar Hospital, Northwest Ethiopia: 2009-2018.

J Parasitol Res. 2021-3-9

[8]
Knowledge and attitude towards cutaneous leishmaniasis among rural endemic communities in Shara'b district, Taiz, southwestern Yemen.

BMC Infect Dis. 2021-3-17

[9]
Prevalence and Risk Factors of Human Leishmaniasis in Ethiopia: A Systematic Review and Meta-Analysis.

Infect Dis Ther. 2021-3

[10]
Interventions for American cutaneous and mucocutaneous leishmaniasis.

Cochrane Database Syst Rev. 2020-8-27

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索